Published in Ann N Y Acad Sci on February 03, 1958
Thiazide effects and adverse effects: insights from molecular genetics. Hypertension (2009) 1.07
Sympathetic stimulation of thiazide-sensitive sodium chloride cotransport in the generation of salt-sensitive hypertension. Hypertension (2014) 0.97
Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J Clin Invest (1960) 0.85
The effects of hydrochlorothiazide and frusemide on noradrenaline sensitivity and blood pressure of salt-loaded rats before and after nephrectomy. Br J Pharmacol Chemother (1968) 0.81
Rationale and methods for the treatment of early essential hypertension. J Natl Med Assoc (1958) 0.75
Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med (1954) 2.24
Hemodynamic alterations in acute myocardial infarction. I. Cardiac output, mean arterial pressure, total peripheral resistance, central and total blood volumes, venous pressure and average circulation time. J Clin Invest (1952) 1.84
The blood volume in congestive heart failure. Trans Assoc Am Physicians (1952) 1.66
The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man. Circulation (1951) 1.64
A study of diagnostic errors. Ann Intern Med (1957) 1.54
Clinical and experimental effects of reserpine in patients with essential hypertension. Ann N Y Acad Sci (1954) 1.48
A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients. Circulation (1954) 1.45
The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium. J Clin Invest (1953) 1.42
The collapse produced by venous congestion of the extremities or by venesection following certain hypotensive agents. J Clin Invest (1951) 1.42
Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation (1959) 1.38
Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. J Am Med Assoc (1958) 1.33
Hemodynamics of hypertension. Physiol Rev (1960) 1.24
The treatment of hypertension with hexamethonium. Circulation (1952) 1.21
Comparison of effects of angiotensin and norepinephrine on pulmonary circulation, systemic arteries and veins, and systemic vascular capacity in the dog. Circulation (1962) 1.21
The effect of hexamethonium as compared to procaine or metycaine lumbar block on the blood flow to the foot of normal subjects. J Clin Invest (1951) 1.17
Experimental and clinical evaluation in man of hexamethonium (C6), a new ganglionic blocking agent. Circulation (1950) 1.14
Potentiating effect of chlorothiazide (diuril) in combination with antihypertensive agents; preliminary report. Med Ann Dist Columbia (1957) 1.14
Needle biopsy as an aid in diagnosis of renal disease. J Lab Clin Med (1953) 1.14
The hemodynamic effects of hypotensive drugs in man; dihydroergocornine. J Clin Invest (1949) 1.14
Transcapillary migration of heavy water and thiocyanate ion in the pulmonary circulation of normal subjects and patients with congestive heart failure. J Clin Invest (1955) 1.12
Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968). Proc Soc Exp Biol Med (1950) 1.11
The effects of hexamethonium on certain manifestations of congestive heart failure. Circulation (1953) 1.10
Renal tubular changes in acute glomerulonephritis. AMA Arch Intern Med (1959) 1.09
The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine. Circulation (1953) 1.09
TREATMENT OF HYPERTENSION WITH DEBRISOQUIN SULFATE (DECLINAX). Curr Ther Res Clin Exp (1965) 1.09
Effects of epinephrine and nor-epinephrine in dogs studied with a mechanical left ventricle; demonstration of active vasoconstriction in the lesser circulation. Am J Physiol (1955) 1.07
Preparation of electrocardiographic data for analysis by digital electronic computer. Circulation (1960) 1.07
The treatment of severe essential hypertension. Med Clin North Am (1950) 1.06
The hemodynamic alterations produced by a plastic valvular prosthesis for severe aortic insufficiency in man. J Clin Invest (1954) 1.06
Five-year survival of patients with malignant hypertension treated with antihypertensive agents. Am Heart J (1960) 1.02
Treatment of hypertension with chlorothiazide. J Am Med Assoc (1959) 1.02
Hemodynamic alterations in hypertensive patients due to chlorothiazide. N Engl J Med (1960) 1.01
Transcapillary exchange rates of deuterium oxide and thiocyanate in the forearm of man. J Appl Physiol (1953) 0.99
Assay in man of the chemical fractions of Veratrum Viride, and identification of the pure alkaloids germitrine and germidine as potent hypotensive principles derived from the drug. J Pharmacol Exp Ther (1950) 0.99
The sympathetic nervous system, the vascular volume and the venous return in relation to cardiovascular integration. Am J Med (1957) 0.99
Rapid and slow components of the circulation in the human forearm. J Clin Invest (1957) 0.98
The discrepancy between home and office recordings of blood pressure in patients under treatment with pentapyrrolidinium; importance of home recordings in adjusting dosages. Med Ann Dist Columbia (1954) 0.96
A method for the study of the circulation in the dog using a mechanical left ventricle. J Appl Physiol (1955) 0.95
The pH of muscle in Laennec's cirrhosis and uremia. Clin Sci (1962) 0.95
Irreversible post-hypoglycemic coma. Am J Med Sci (1951) 0.94
The role hypertension. Am J Public Health Nations Health (1960) 0.92
The blood volume in congestive heart failure. J Clin Invest (1950) 0.92
Relationship between electrocardiographic changes and hypokalemia in insulin-induced hypoglycemia. Am Heart J (1952) 0.92
Essential hypertension; therapeutic trial of veriloid, a new extract of Veratrum viride. Proc Soc Exp Biol Med (1949) 0.91
Clinical appraisal of hexamethonium (C6) in peripheral vascular diseases. N Engl J Med (1951) 0.90
Hemodynamic effects of guanethidine in man. Circ Res (1963) 0.90
Changes in the volume of the plasma, interstitial and intracellular fluid spaces during hydration and dehydration in normal and edematous subjects. Am J Med (1949) 0.88
The relation between glomerular function and histology in acute glomerulonephritis. J Lab Clin Med (1961) 0.88
Results of prolonged treatment with pentolinium tartrate with special reference to the addition of Rauwolfia, hydralazine or both. Circulation (1956) 0.87
Cerebral complications of hypotension. Ann Intern Med (1955) 0.87
Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J Clin Invest (1960) 0.85
Alterations in systemic vascular volume of the dog in response to hexamethonium and norepinephrine. Am J Physiol (1957) 0.85
The hematocrit of the lesser circulation in man. J Clin Invest (1956) 0.84
The effects of a variety of hemodynamic changes on the rapid and slow components of the circulation in the human forearm. J Clin Invest (1958) 0.84
HYDRODYNAMICS OF AORTIC BLOOD FLOW. Circ Res (1964) 0.84
Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium. Circulation (1952) 0.84
The influence of shock on cerebral hemodynamics and metabolism. Am J Med Sci (1955) 0.83
Macroglobulinemia an amyloid nephrosis. Report of a case. Med Ann Dist Columbia (1961) 0.83
Clinical trial of guanethidine, a new type of antihypertensive agent. Med Ann Dist Columbia (1959) 0.82
Chlorpromazine-induced diuresis. J Lab Clin Med (1956) 0.81
The phenomenon of "congestion collapse"; its pathogenesis and significance. J Clin Invest (1950) 0.81
Estimation of residual and end-diastolic volumes of the right ventricle of men without heart disease, using the dye-dilution method. Am Heart J (1960) 0.81
Kidney biopsy; a review of one hundred successful needle biopsies. AMA Arch Intern Med (1955) 0.80
Hypokaliemia in porphyria. Med Ann Dist Columbia (1953) 0.80
Renal and cerebral hemodynamics with hypotension. Am J Med Sci (1957) 0.80
Effect of ACTH on responsiveness to insulin. Metabolism (1953) 0.79
Veratrum viride and hexamethonium in the treatment of severe diastolic hypertension. Med Ann Dist Columbia (1951) 0.79
TRIAMTERENE WITH HYDROCHLOROTHIAZIDE IN THE TREATMENT OF HYPERTENSION. JAMA (1963) 0.79
Rational elimination of side reactions and/or tolerance in the development of potentially valuable drugs. Angiology (1952) 0.79
Evaluation of I131-labelled diodrast renograms with suggestions on improving the technic. Med Ann Dist Columbia (1959) 0.79
Effect of pentaquine in patients with hypertension. Proc Soc Exp Biol Med (1947) 0.78
Renal, transcapillary, net exchange in the dog. Circ Res (1958) 0.78
Membranous glomerulonephritis. AMA Arch Intern Med (1957) 0.78
EFFECT OF AMYL NITRITE ON THE HEIGHT OF THE PULSE WAVE INCISURA IN ATHEROSCLEROTIC PATIENTS. Angiology (1964) 0.77
Apparent remission of a severe diabetic on developing the Kimmelstiel-Wilson syndrome. Ann Intern Med (1961) 0.77
HYDRALAZINE IN HYPERTENSION. Am Heart J (1964) 0.77
A clinical evaluation of veratrum viride in the treatment of essential hypertension. Am Heart J (1948) 0.77
OFFICE EVALUATION OF THE HYPERTENSIVE PATIENT. I. Mod Concepts Cardiovasc Dis (1963) 0.76
Observations on the development of tolerance during prolonged oral administration of dihydroergocornine. J Pharmacol Exp Ther (1949) 0.76
Selective inhibition of the sympathetic nervous system in man with bretylium tosylate, a new antihypertensive agent. Circulation (1960) 0.76
Mecamylamine, a new, orally effective, hypotensive agent; experimental and clinical evaluation. AMA Arch Intern Med (1956) 0.76
Antihypertensive agents. I. N Engl J Med (1962) 0.76
The effects of certain dihydrogenated alkaloids of ergot in hypertensive patients. Am J Med Sci (1948) 0.76
The serum uric acid concentration in essential hypertension. Proc Soc Exp Biol Med (1947) 0.76
Mechanism of the antihypertensive effects of diuretics. Possible role of salt in hypertension. Clin Pharmacol Ther (1960) 0.75
Rationale and methods for the treatment of early essential hypertension. J Natl Med Assoc (1958) 0.75
Effect of desoxycorticosterone acetate on insulin sensitivity in diabetes mellitus. Proc Soc Exp Biol Med (1950) 0.75
Changes in responsiveness to insulin in diabetes mellitus induced by the administration of desoxycorticosterone. J Clin Endocrinol Metab (1950) 0.75
TREATMENT OF HYPERTENSION: EFFECT ON MORBIDITY AND MORTALITY. Listing Res Cardiovasc Field (1964) 0.75
The physiologic basis for the treatment of diabetic coma. Med Ann Dist Columbia (1949) 0.75
METHYLDOPA IN THE TREATMENT OF HYPERTENSION. Med Ann Dist Columbia (1965) 0.75
PRESSOR DRUGS IN THE TREATMENT OF VARIOUS FORMS OF SHOCK. Listing Res Cardiovasc Field (1964) 0.75